|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.05 USD | -1.42% |
|
-1.44% | +13.10% |
| 06:56am | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| Jun. 12 | Merck Wins FDA Approvals for Keytruda Combination in Kidney Cancer | DJ |
| Market Cap | 294B 254B 234B 219B 411B 27,948B 417B 2,763B 1,077B 13,603B 1,104B 1,080B 47,101B | P/E Ratio 2026 * |
53.1x | P/E Ratio 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 330B 285B 263B 246B 461B 31,406B 468B 3,105B 1,211B 15,286B 1,240B 1,214B 52,929B | EV / Sales 2026 * |
4.94x | EV / Sales 2027 * | 4.52x |
| Free-Float |
69% | Yield 2026 * |
2.81% | Yield 2027 * | 2.91% |
Last Transcript: Merck & Co., Inc.
| 1 day | -1.42% | ||
| 1 week | -1.44% | ||
| Current month | +0.28% | ||
| 1 month | +4.97% | ||
| 3 months | +2.98% | ||
| 6 months | +18.69% | ||
| Current year | +13.10% |
| 1 week | 117.26 |  | 122.71 |
| 1 month | 110.97 | | 123.46 |
| Current year | 104.43 | | 125.14 |
| 1 year | 76.66 | | 125.14 |
| 3 years | 73.31 | | 134.63 |
| 5 years | 70.89 | | 134.63 |
| 10 years | 52.83 | | 134.63 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 59 | 2021-06-30 |
| Director of Finance/CFO | 57 | 2021-03-31 | |
Marjorie Green
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 65 | 2007-11-26 |
Patricia Russo
BRD | Director/Board Member | 73 | 1995-08-31 |
Robert Davis
CHM | Chairman | 59 | 2022-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 28 | Other | Director | 1,853 | 0.0001% | ||
| May. 28 | Other | Director | 1,853 | 0.0001% | ||
| May. 28 | Other | Director | 1,853 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | -1.44% | +45.70% | +9.56% | 294B | |
| +0.68% | -2.76% | +16.57% | -18.61% | 67.08B | |
| -0.50% | +1.10% | -4.31% | -11.62% | 7.84B | |
| -0.68% | -0.23% | -2.66% | +9.74% | 4.54B | |
| +1.05% | -0.39% | -27.51% | +36.69% | 3.8B | |
| +2.01% | +10.19% | -14.95% | +9.40% | 3.35B | |
| -2.50% | -0.76% | +38.65% | +31.35% | 2.58B | |
| +3.11% | +1.30% | +5.67% | -21.79% | 1.98B | |
| +1.99% | -2.79% | -19.58% | -23.33% | 1.73B | |
| +2.64% | -1.17% | +10.17% | +18.43% | 1.65B | |
| Average | +0.64% | +3.03% | +4.78% | +3.98% | 38.86B | |
| Weighted average by Cap. | -0.93% | -1.19% | +37.17% | +4.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 66.85B 57.74B 53.2B 49.8B 93.33B 6,354B 94.78B 628B 245B 3,093B 251B 246B 10,708B | 70.15B 60.59B 55.84B 52.26B 97.95B 6,668B 99.46B 659B 257B 3,246B 263B 258B 11,238B |
| Net income | 5.56B 4.8B 4.42B 4.14B 7.76B 528B 7.88B 52.21B 20.36B 257B 20.85B 20.41B 890B | 20.43B 17.64B 16.26B 15.22B 28.52B 1,941B 28.96B 192B 74.84B 945B 76.66B 75.02B 3,272B |
| Net Debt | 36.38B 31.42B 28.95B 27.1B 50.79B 3,458B 51.58B 342B 133B 1,683B 137B 134B 5,828B | 23.18B 20.02B 18.45B 17.27B 32.36B 2,203B 32.86B 218B 84.93B 1,072B 86.99B 85.14B 3,713B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 119.05 $ | -1.42% | 10,927,107 |
| 26-06-11 | 120.76 $ | +1.40% | 13,180,276 |
| 26-06-10 | 119.09 $ | -0.43% | 10,302,107 |
| 26-06-09 | 119.60 $ | +0.07% | 9,669,142 |
| 26-06-08 | 119.52 $ | -1.05% | 12,312,220 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRK Stock
Select your edition
All financial news and data tailored to specific country editions
